The preliminary programme for Rudolf Buchheim 200: New Essays on the Doctrine of Drugs

Thursday, 9 September

18.00 - 18.10 Opening

18.10 - 18.40


Plenary lecture
History of Chemistry in University of Tartu
Prof. Enn Lust, University of Tartu

18.40 - 19.40


Plenary lecture
Rudolf Buchheim - materia medica becomes modern pharmacology
Prof. Lars Oreland, Uppsala University
19.40 - 22.00

Welcome reception in the White Hall of the University of Tartu Museum and in the Old Anatomical Theatre

The Welcome Reception will take place both in the Old Anatomical Theatre and the White Hall of the University of Tartu Museum. More information will be provided to registered participants before the event.


Friday, 10 September

University of Tartu main building

8.15 - 8.20


 Prof. Toomas Asser,  Rector of the University of Tartu

8.20 - 9.30



Plenary lecture
Pharmacogenetics in psychopharmacology: approaches of individualization
Prof. Ingolf Cascorbi, Kiel University, President of International Union of Basic and Clinical Pharmacology (IUPHAR)

9.30 Parallel symposia

Neuropsychopharmacology 1


The legacy of Arvid Carlsson: the past, present and future of psychopharmacology
Prof. Elias Eriksson, University of Gothenburg


Pharmacological application of growth factors
Prof. Raimo Tuominen, University of Helsinki


The potential of neuropeptides in psychopharmacology - insights from animal models
Prof. David J. Slattery, Johann Wolfgang Goethe-Universität Frankfurt am Main


Personalized psychopharmacology through animal models
Prof. Jaanus Harro, University of Tartu and North Estonia Medical Centre


Prof. Mart Saarma, University of Helsinki

Recent Advancements in Drug Design and Delivery


Nanocrystal based formulations in drug delivery
Prof. Leena Peltonen, University of Helsinki


Finding new RNA targeting drug molecules
Prof. Mati Karelson, University of Tartu


Peptide-based drug delivery systems: preclinical development and applications in biotechnology
Dr Kaido Kurrikoff, University of Tartu  


Preclinical and clinical development of vascular homing peptides for precision medicine
Prof. Tambet Teesalu, University of Tartu

12.00 Oswald Schmiedeberg lecture 
Prof. Tomas Hökfelt, Karolinska Institutet
12.45 Lunch
13.45 Parallel symposia



PGx of TKI resistance
Prof. Ingolf Cascorbi, Kiel University, President of International Union of Basic and Clinical Pharmacology (IUPHAR)


Current and future drugs in immunotherapy
Prof. Pärt Peterson, University of Tartu


Endocrine side effects of new oncological drugs
Prof. Vallo Volke, University of Tartu


Latest developments in pharmacotherapy of cancer
Dr Kersti Oselin, North Estonia Medical Centre


New developments in immunotherapy 


Early phase clinical trials

Network for European Clinical Trials for Children


From microsampling to miniature mass spectrometers - advances in bioanalysis with limited sample volume
Dr Karin Kipper, Epilepsy Society, Head of Therapeutic Drug Monitoring Unit, the UK


The effects of augmented renal clearance on the pharmacokinetic profile of antibiotics
Dr Lenne-Triin Kõrgvee, Tartu University Hospital, University of Tartu


Measurement of glomerular filtration rate using iohexol
Dr Hiie Soeorg, University of Copenhagen


Vancomycin and DosOpt 
Dr Riste Kalamees, Tartu University Hospital, University of Tartu


Pharmacokinetics  of spironolactone in children under 2 years
Dr Jana Lass, Tartu University Hospital, University of Tartu 


Pharmacokinetics and concentration related effects of dobutamine in neonates
Dr Maarja Hallik, East Tallinn Central Hospital











Emerging drugs in Endocrinology and Diabetes


Acute and Chronic Metabolic effects of Melatonin
Prof. Ulla Kampmann Opstrup, Steno Diabetes Center Aarhus and Aarhus University


Citrulline - more than just an amino acid
Prof. Alastair Forbes, Norwich Medical School, University of East Angla, the UK and University of Tartu


Long-acting amylin analogue: effects on weight and glycaemia
Dr Kirsten Raun, Scientific director, NovoNordisk


Secrets of GLP-1 receptor agonists
Prof. Vallo Volke, University of Tartu


New drugs for osteoporosis
Prof. Ugis Gruntmanis, Geisel School of Medicine at Dartmouth, USA


Short communications

17.15 - 18.45 Excursion in the city with a small coffee break
20.00 - 23.00 Gala Dinner at the Athena Centre


Saturday, 11 September

University of Tartu main building

8.20 - 8.50


Plenary lecture

Pharmacovigilance: from reactive to proactive and predictive
Prof. Lembit Rägo, Secretary-General of Council for International Organizations of Medical Sciences (CIOMS)

8.50 - 10.00

Plenary lecture

Can dysregulated myelination be linked to ADHD pathogenesis and does this generate new treatment targets?
Prof. Klaus-Peter Lesch, University Hospital of Würzburg

10.00 Parallel symposia

Neuropsychopharmacology 2


Prof. Edwin Zvartau, First Saint Petersburg State Pavlov Medical University


Dr Ilja Sukhanov, First Saint Petersburg State Pavlov Medical University


Epigenetics and Psychostimulant Addiction
Prof. Anti Kalda, University of Tartu


Extended release naltrexone for opioid use disorders: Advantages and problems
Prof. Evgeny Krupitsky, First Saint Petersburg State Pavlov Medical University


Neuronal plasticity and neurotrophin signaling in the antidepressant effect
Prof. Eero Castrén, University of Helsinki

New drugs in Cardiology


How to combine antiplatelet and anticoagulant drugs?
Dr. Alar Irs, Tartu University Hospital and Estonian State Agency of Medicines


How to minimize the risk of arrhythmia with QT-prolonging drugs?
Dr. Jessica Schubert, Uppsala University Hospital


New drugs for treating dyslipidemia
Dr. Martin Serg, North Estonia Medical Centre


E-solutions to detect drug- drug interactions


Closing remarks

14.00 - 16.30 Excursion to the Estonian National Museum

The programme is subject to change.